274
M. Piest et al. / Journal of Controlled Release 169 (2013) 266–275
these conditions. In previous work we have incorporated additional cat-
ionic segments in the main chain of p(CBA-ABOL) to modify this poly-
mer suitable for siRNA delivery [43].
References
[1] I.M. Verma, N. Somia, Gene therapy — promises, problems and prospects, Nature
389 (1997) 239–242.
[2] S.Y. Wong, J.M. Pelet, D. Putnam, Polymer systems for gene delivery-past, present,
and future, Prog. Polym. Sci. 32 (2007) 799–837.
[3] E. Wagner, J. Kloeckner, Gene delivery using polymer therapeutics, Adv. Polym.
Sci. 192 (2006) 135–173.
4. Conclusion
[4] S.B. Zhang, Y.M. Xu, B. Wang, W.H. Qiao, D.L. Liu, Z.S. Li, Cationic compounds used
in lipoplexes and polyplexes for gene delivery, J. Control. Release 100 (2004)
165–180.
[5] J. Luten, C.F. van Nostruin, S.C. De Smedt, W.E. Hennink, Biodegradable polymers as
non-viral carriers for plasmid DNA delivery, J. Control. Release 126 (2008) 97–110.
[6] T.G. Park, J.H. Jeong, S.W. Kim, Current status of polymeric gene delivery systems,
Adv. Drug Deliv. Rev. 58 (2006) 467–486.
[7] C. Lin, Z.Y. Zhong, M.C. Lok, X.L. Jiang, W.E. Hennink, J. Feijen, J.F.J. Engbersen, Novel
bioreducible poly(amido amine)s for highly efficient gene delivery, Bioconjug.
Chem. 18 (2007) 138–145.
[8] C. Lin, C.J. Blaauboer, M.M. Timoneda, M.C. Lok, M. van Steenbergen, W.E. Hennink, Z.Y.
Zhong, J. Feijen, J.F.J. Engbersen, Bioreducible poly(amido amine)s with oligoamine side
chains: synthesis, characterization, and structural effects on gene delivery, J. Control.
Release 126 (2008) 166–174.
[9] C. Lin, J.F.J. Engbersen, Effect of chemical functionalities in poly(amido amine)s
for non-viral gene transfection, J. Control. Release 132 (2008) 267–272.
[10] C. Lin, Z.Y. Zhong, M.C. Lok, X.J. Jiang, W.E. Hennink, J. Feijen, J.F.J. Engbersen, Ran-
dom and block copolymers of bioreducible poly(amido amine)s with high- and
low-basicity amino groups: study of DNA condensation and buffer capacity on
gene transfection, J. Control. Release 123 (2007) 67–75.
[11] C. Lin, Z.Y. Zhong, M.C. Lok, X.L. Jiang, W.E. Hennink, J. Feijen, J.F.J. Engbersen,
Linear poly(amido amine)s with secondary and tertiary amino groups and vari-
able amounts of disulfide linkages: synthesis and in vitro gene transfer proper-
ties, J. Control. Release 116 (2006) 130–137.
[12] L.V. Christensen, C.W. Chang, W.J. Kim, S.W. Kim, Z.Y. Zhong, C. Lin, J.F.J. Engbersen, J.
Feijen, Reducible poly(amido ethylenimine)s designed for triggered intracellular
gene delivery, Bioconjug. Chem. 17 (2006) 1233–1240.
[13] M.A. Mateos-Timoneda, M.C. Lok, W.E. Hennink, J. Feijen, J.F.J. Engbersen,
Poly(amido amine)s as gene delivery vectors: effects of quaternary nicotinamide
moieties in the side chains, ChemMedChem 3 (2008) 478–486.
[14] M. Piest, C. Lin, M.A. Mateos-Timoneda, M.C. Lok, W.E. Hennink, J. Feijen, J.F.J.
Engbersen, Novel poly(amido amine)s with bioreducible disulfide linkages in their
diamino-units: structure effects and in vitro gene transfer properties, J. Control.
Release 130 (2008) 38–45.
A multifunctional poly(amido amine), p(CBA-ABOL/2AMPBA),
was developed containing tertiary amines that are protonable in
the endosomal acidification range, disulfide groups that are cleavable
in the reducing intracellular environment, hydroxybutyl groups that in-
teract with the endosomal membrane, and 2-aminomethylboronic acid
groups that reversibly interact with amino and hydroxyl groups in
nanoparticles and polyplexes and form boronic esters with vicinal diol
groups as are present in e.g. carbohydrates. The boronic acid groups in
p(CBA-ABOL/2AMPBA) stabilize self-assembled nanoparticles and DNA-
and siRNA-polyplexes formed at physiological pH, due to reversible
crosslink formation between the Lewis acidic 2AMPBA group and neigh-
boring Lewis bases. This architectural picture is supported by the fact
that D-sorbitol, that can compete with the crosslinking groups for bind-
ing to 2AMPBA, destabilizes DNA polyplexes of p(CBA-ABOL/2AMPBA)
at 24/1 polymer/DNA ratio. The high stability of p(CBA-ABOL/2AMPBA)
polyplexes with pDNA (at least 6 days at 37 °C) and with siRNA (at
least 4 days at 37 °C) is a remarkable and favorable property of these
polyplexes. The stability can be further enhanced by self-assembled dec-
oration of dextran to the surface of these polyplexes. Since p(CBA-ABOL)
polyplexes gave higher transfection than p(CBA-ABOL/2AMPBA)
polyplexes in three different cell lines tested, COS-7, HUH-6, and
H1299-Fluc, it can be concluded that the presence of the 2AMPBA
moieties has an overall unfavorable effect on the DNA transfection
efficiency. Most probably this can be primarily attributed to binding
of the p(CBA-ABOL/2AMPBA) polyplexes to glycoproteins on the sur-
face of the cells, thereby hampering the cellular uptake of the
polyplexes. Support for this explanation was found in the observation
that the presence of D-sorbitol and dextran in the polyplex medium in-
creases the transfection efficiency. Then, available 2AMPBA groups bind
with sorbitol and dextran to form boronic esters, which reduces the
binding affinity of the polyplexes with the glycocalix of the cells. The re-
sults furthermore show that polyplexes of siRNA with p(CBA-ABOL/
2AMPBA) are more effective delivery vectors in gene silencing than
polyplexes from p(CBA-ABOL). This can be attributed to the higher sta-
bility of the p(CBA-ABOL/2AMPBA) polyplexes with their dynamical
crosslinking boronated moieties. The knockdown of gene expression
by the siRNA polyplexes could be enhanced by the addition of sorbitol,
and in particular dextran, to the polyplex solution. For polyplexes of
p(CBA-ABOL/2AMPBA) this effect can be explained by reduced binding
interactions with the glycocalix, however the origin of this effect is less
clear for p(CBA-ABOL) polyplexes which are lacking specific binding
sites for carbohydrates. The enhanced gene silencing together with the
excellent stability of siRNA polyplexes with p(CBA-ABOL/2AMPBA), as
well as their good possibilities for carbohydrate decoration, makes this
multifunctional polymer a very promising candidate for siRNA delivery.
[15] M. Piest, J.F.J. Engbersen, Role of boronic acid moieties in disulfide containing
poly(amido amine)s for non-viral gene delivery, J. Control. Release 155 (2011)
331–340.
[16] D.G. Hall, Boronic Acids — Preparation and Applications in Organic Synthesis and
Medicine, John Wiley & Sons, 2005.
[17] T.D. James, M.D. Phillips, S. Shinkai, Boronic Acids in Saccharide Recognition,
Royal Society of Chemistry, Cambridge, 2006.
[18] J. Yan, H. Fang, B.H. Wang, Boronolectins and fluorescent boronolectins: an examina-
tion of the detailed chemistry issues important for the design, Med. Res. Rev. 25
(2005) 490–520.
[19] G. Springsteen, B. Wang, A detailed examination of boronic acid–diol complexa-
tion, Tetrahedron 58 (2002) 5291–5300.
[20] J. Yan, G. Springsteen, S. Deeter, B.H. Wang, The relationship among pK(a), pH,
and binding constants in the interactions between boronic acids and diols — it
is not as simple as it appears, Tetrahedron 60 (2004) 11205–11209.
[21] A.E. Ivanov, J. Eccles, H.A. Panahi, A. Kumar, M.V. Kuzimenkova, L. Nilsson, B.
Bergenståhl, N. Long, G.J. Phillips, S.V. Mikhalovsky, I.Y. Galaev, B. Mattiasson,
Boronate-containing polymer brushes: characterization, interaction with saccha-
rides and mammalian cancer cells, J. Biomed. Mater. Res. A 88A (2009) 213–225.
[22] N.D. Winblade, H. Schmokel, M. Baumann, A.S. Hoffman, J.A. Hubbell, Sterically
blocking adhesion of cells to biological surfaces with a surface-active copolymer
containing poly(ethylene glycol) and phenylboronic acid, J. Biomed. Mater. Res.
59 (2002) 618–631.
[23] W.Q. Yang, X.M. Gao, B.H. Wang, Boronic acid compounds as potential pharmaceutical
agents, Med. Res. Rev. 23 (2003) 346–368.
[24] S. Moffatt, S. Wiehle, R.J. Cristiano, Tumor-specific gene delivery mediated by a novel
peptide–polyethylenimine–DNA polyplex targeting aminopeptidase N/CD13, Hum.
Gene Ther. 16 (2005) 57–67.
[25] G.A. Ellis, M.J. Palte, R.T. Raines, Boronate-mediated biologic delivery, J. Am. Chem.
Soc. 134 (2012) 3631–3634.
[26] Q. Peng, F. Chen, Z. Zhong, R. Zhuo, Enhanced gene transfection capability of
polyethylenimine by incorporating boronic acid groups, Chem. Commun. 46
(2010) 5888–5890.
[27] F. Chen, Z. Zhang, M. Cai, X. Zhang, Z. Zhong, R. Zhuo, Phenylboronic-acid-modified
amphiphilic polyether as a neutral gene vector, Macromol. Biosci. 12 (2012) 962–969.
[28] M.R. Dreher, W. Liu, C.R. Michelich, M.W. Dewhirst, F. Yuan, A. Chilkoti, Tumor
vascular permeability, accumulation, and penetration of macromolecular drug
carriers, J. Natl. Cancer Inst. 98 (2006) 335–344.
Acknowledgments
The authors thank the Netherlands Organization for Scientific Re-
search (NOW) for the financial support in the framework of their ECHO
program, Anika Embrechts for her help with the AFM measurements,
Tom Groothuis for his help with the confocal microscopy measurements,
and Anouk Mentink-Leusink and Hemant V. Unadkat for their help with
the automated fluorescence microscopy.
[29] A. Matsumoto, H. Cabral, N. Sato, K. Kataoka, Y. Miyahara, Assessment of tumor
metastasis by the direct determination of cell-membrane sialic acid expression,
Angew. Chem. Int. Ed. 49 (2010) 5494–5497.
Appendix A. Supplementary data
[30] A. Mahalingam, A.R. Geonnotti, J. Balzarini, P.F. Kiser, Activity and safety of syn-
thetic lectins based on benzoboroxole-functionalized polymers for inhibition of
HIV entry, Mol. Pharm. 8 (2011) 2465–2475.
Supplementary data to this article can be found online at http://